Exagen Basic Shares Outstanding 2019-2024 | XGN
Exagen basic shares outstanding from 2019 to 2024. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
| Exagen Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $18 |
| 2023 | $18 |
| 2022 | $17 |
| 2021 | $16 |
| 2020 | $13 |
| 2019 | $4 |
| 2018 | $0 |
| Exagen Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024-12-31 | $18 |
| 2024-09-30 | $18 |
| 2024-06-30 | $18 |
| 2024-03-31 | $18 |
| 2023-12-31 | $18 |
| 2023-09-30 | $18 |
| 2023-06-30 | $18 |
| 2023-03-31 | $18 |
| 2022-12-31 | $17 |
| 2022-09-30 | $17 |
| 2022-06-30 | $17 |
| 2022-03-31 | $17 |
| 2021-12-31 | $16 |
| 2021-09-30 | $17 |
| 2021-06-30 | $17 |
| 2021-03-31 | $13 |
| 2020-12-31 | $13 |
| 2020-09-30 | $13 |
| 2020-06-30 | $13 |
| 2020-03-31 | $13 |
| 2019-12-31 | $4 |
| 2019-09-30 | $2 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | |
| 2018-09-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.108B | $0.056B |
| Exagen Inc. is engaged in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases. It developed and commercialises testing products under AVISE brand. Exagen Inc. is based in Vista, California. | |||